While pregnant, women need to be especially careful about what foods and medications that they put into their bodies. Early in the first trimester, while many women are not even aware that they are pregnant, the baby is at a heightened risk for birth defects due to medications being ingested by their mother. Our birth defects attorneys have been writing for months about the drug Topamax and its connection to cleft lip and palate birth defects.
Mothers Taking Active Ingredient in Topamax Three Times More Likely to have Children with Birth Defects
A recent study called Comparative Safety of Topiramate During Pregnancy, performed by researchers from Harvard University, MassGeneral Hospital for Children, and Loyola University in Chicago, has come to the conclusion that topiramate increases chances of birth defects. According to the study, women who take the active ingredient in the medication Topamax during their first trimester of pregnancy increase the risk of their children being born with major oral birth defects. The study analyzed statistics of 6,456 pregnant women and “compared the frequency of adverse pregnancy outcomes for those who had used topiramate during their first trimester to a control group.” The results were that the children whose mothers took topiramate were almost three times more likely to be born with a birth defect, 3.8 %, than the mothers who did not, 1.3 %.
Birth Defects Lawyers in New Jersey and Philadelphia
If you are a pregnant and currently taking Topamax or any drug containing topiramate, speak with your doctor as soon as possible about other, safer options. If you are a parent who has recently given birth to a child who suffers from a birth defect that you believe can be attributed to a prescription drug, contact the Mininno Law Office to speak with birth defects lawyers and discuss your legal rights. You may also call for a free case evaluation and consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.
Months ago, the Mininno Law Office blog posted about the anti-epileptic drug Topamax, which was shown to cause oral malformations, such as cleft lip or cleft palate, in newborns whose mothers took the drug during pregnancy. The FDA recently changed the drug’s classification from 
In 2004, New York’s highest court ruled that women can sue for emotional suffering if their stillbirth is a result of medical malpractice. There have now been a couple cases moving through the legal system that are determining what is justified compensation.
When a child is between the ages of six weeks and nine months, surgery is usually done to close the cleft lip. Additional surgery may also be necessary down the road if the cleft has a major effect on the nose and the surrounding area. If the cleft lip can be successfully closed by this initial surgery, it becomes much more likely that the child will have normal speech developments as the aging process continues. During the early months however, a prosthetic is sometimes inserted temporarily to close a baby’s palate to ensure that a baby can receive the proper food and nutrients. When a baby is able to take in the proper amount of nutrients, even with the cleft lip and cleft palate, lawyers say that growth and weight issues are not nearly as likely.
In the early development of a fetus (the first three months of pregnancy), the lips and palate develop separately. Since the development is not simultaneous, babies may be born with only a cleft lip, a cleft palate, or in some cases both. When parts of the lip or palate do not completely come together, the orofacial problems begin to develop. There can also be many variations in the different types of clefts. A cleft can occur only on one side of the mouth, known as a unilateral cleft, or on both sides of the mouth, known as a bilateral cleft. Young girls are more likely to have a cleft palate that occurs alone. On the other hand, an oral cleft, regardless of whether it is lip or palate, is generally more common in boys.